JP2017019841A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017019841A5 JP2017019841A5 JP2016174646A JP2016174646A JP2017019841A5 JP 2017019841 A5 JP2017019841 A5 JP 2017019841A5 JP 2016174646 A JP2016174646 A JP 2016174646A JP 2016174646 A JP2016174646 A JP 2016174646A JP 2017019841 A5 JP2017019841 A5 JP 2017019841A5
- Authority
- JP
- Japan
- Prior art keywords
- maintenance
- improvement
- qol
- improving
- maintaining
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000012423 maintenance Methods 0.000 claims 16
- 239000003795 chemical substances by application Substances 0.000 claims 6
- 241000186660 Lactobacillus Species 0.000 claims 3
- 208000027499 body ache Diseases 0.000 claims 3
- 229940039696 lactobacillus Drugs 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2011080814 | 2011-03-31 | ||
| JP2011080814 | 2011-03-31 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013507674A Division JP6061842B2 (ja) | 2011-03-31 | 2012-03-28 | Ｑｏｌ改善又は持続剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017019841A JP2017019841A (ja) | 2017-01-26 |
| JP2017019841A5 true JP2017019841A5 (enExample) | 2017-03-16 |
| JP6261688B2 JP6261688B2 (ja) | 2018-01-17 |
Family
ID=46931242
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013507674A Active JP6061842B2 (ja) | 2011-03-31 | 2012-03-28 | Ｑｏｌ改善又は持続剤 |
| JP2016174646A Active JP6261688B2 (ja) | 2011-03-31 | 2016-09-07 | Ｑｏｌ改善又は持続剤 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013507674A Active JP6061842B2 (ja) | 2011-03-31 | 2012-03-28 | Ｑｏｌ改善又は持続剤 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US9623054B2 (enExample) |
| EP (1) | EP2692349B1 (enExample) |
| JP (2) | JP6061842B2 (enExample) |
| KR (1) | KR101878525B1 (enExample) |
| CN (1) | CN103458905A (enExample) |
| AU (1) | AU2012233590B2 (enExample) |
| CA (1) | CA2831554C (enExample) |
| ES (1) | ES2617989T3 (enExample) |
| PH (1) | PH12013501951A1 (enExample) |
| SG (3) | SG10201602487SA (enExample) |
| TW (1) | TWI642363B (enExample) |
| WO (1) | WO2012133533A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017183595A1 (ja) * | 2016-04-20 | 2017-10-26 | 株式会社 明治 | 疲労感の改善用の発酵乳 |
| TWI583388B (zh) * | 2016-08-24 | 2017-05-21 | 國立體育大學 | 胚芽乳酸桿菌用於製備改善運動表現及降低肌肉疲勞之益生菌組合物之用途 |
| AU2020289102B2 (en) * | 2019-06-03 | 2025-07-03 | Asahi Group Holdings, Ltd. | Walking ability improver |
| JP7593740B2 (ja) * | 2020-03-02 | 2024-12-03 | 株式会社明治 | 睡眠の質改善用組成物、全体的健康感改善用組成物および活力向上用組成物 |
| JP7703165B2 (ja) * | 2020-07-27 | 2025-07-07 | 独立行政法人国立病院機構 | Ｑｏｌ改善剤 |
| TW202442251A (zh) * | 2023-04-12 | 2024-11-01 | 葡萄王生技股份有限公司 | 抗疲勞乳酸菌組成物及其用途 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2004249060A1 (en) * | 2003-06-24 | 2004-12-29 | Otsuka Pharmaceutical Co., Ltd. | Composition for lowering serum uric acid level |
| DE602004030922D1 (de) * | 2003-08-21 | 2011-02-17 | Otsuka Pharma Co Ltd | Milchsäurebakterien mit mucosa-immunpotenzierungseffekt |
| CN101128122B (zh) * | 2005-02-23 | 2011-02-09 | 大塚制药株式会社 | 基于茶的发酵饮料和茶饮料 |
| US8182849B2 (en) | 2005-02-23 | 2012-05-22 | Otsuka Pharmaceutical Co., Ltd. | Fermented tea beverage and tea beverage |
| JP5467785B2 (ja) * | 2009-03-25 | 2014-04-09 | 大塚製薬株式会社 | 抗鳥インフルエンザウイルス抗体の産生促進剤 |
-
2012
- 2012-03-28 CA CA2831554A patent/CA2831554C/en active Active
- 2012-03-28 EP EP12762904.6A patent/EP2692349B1/en active Active
- 2012-03-28 ES ES12762904.6T patent/ES2617989T3/es active Active
- 2012-03-28 US US14/008,325 patent/US9623054B2/en active Active
- 2012-03-28 JP JP2013507674A patent/JP6061842B2/ja active Active
- 2012-03-28 SG SG10201602487SA patent/SG10201602487SA/en unknown
- 2012-03-28 SG SG2013069984A patent/SG193508A1/en unknown
- 2012-03-28 SG SG10201912606QA patent/SG10201912606QA/en unknown
- 2012-03-28 WO PCT/JP2012/058145 patent/WO2012133533A1/ja not_active Ceased
- 2012-03-28 AU AU2012233590A patent/AU2012233590B2/en active Active
- 2012-03-28 PH PH1/2013/501951A patent/PH12013501951A1/en unknown
- 2012-03-28 KR KR1020137028373A patent/KR101878525B1/ko active Active
- 2012-03-28 CN CN2012800144844A patent/CN103458905A/zh active Pending
- 2012-03-29 TW TW101111098A patent/TWI642363B/zh active
-
2016
- 2016-09-07 JP JP2016174646A patent/JP6261688B2/ja active Active
-
2017
- 2017-04-17 US US15/488,623 patent/US10369177B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017019841A5 (enExample) | ||
| PH12018500810A1 (en) | Antibody agents specific for human cd19 and uses thereof | |
| SG10201903823QA (en) | Methods and compositions relating to microbial treatment and diagnosis of disorders | |
| UY31305A1 (es) | Derivados de 1,2,4,5-tetrahidro-3h-benzazepinas, su procedimiento de preparacion y las composiciones farmacéuticas que las contienen. | |
| CO6771406A2 (es) | Una composición combinada | |
| JP2020536085A5 (enExample) | ||
| CL2016000160A1 (es) | Pelicula oral que comprende hidroxipropilcelulosa sola o combinada con polivinilpirrolidona, al menos un copolímero de vinilpirrolidona, dioxido de titanio, en donde la relación del copolímero de vinilpirrolidona con el dioxido de titanio es de 3 es a 1 a 5 es a 1, y rizatriptán, zolmitriptán, alprazolam, diazepam o lorazepam, como principio activo. | |
| WO2016074641A8 (zh) | Nadh或其盐在制备治疗苯丙酮尿症药物或保健品的应用 | |
| JP2018035153A5 (enExample) | ||
| EA202191106A1 (ru) | Пробиотическая добавка для метаболического здоровья, содержащая lactobacillus | |
| GB0606848D0 (en) | Product, method of manufacture and use | |
| WO2015168656A3 (en) | Biological complexes and methods for using same | |
| JP2016175884A5 (enExample) | ||
| MX2021009992A (es) | Formulacion microbiana de intestino de abeja para su uso como un probiotico para salud mejorada y resistencia a patogenos de las abejas. | |
| WO2016027225A8 (en) | A composition having a muscle-relaxant and anti-inflammatory activity | |
| MX2025002392A (es) | Formulaciones de dantroleno y metodos de uso de dichas formulaciones | |
| JP2014101288A5 (enExample) | ||
| JP2014240383A5 (enExample) | ||
| AR109457A1 (es) | Método para el tratamiento de la ame y composición farmacéutica | |
| Komine et al. | Study on the problem and the effect when a handicapped person made furniture. The proposal of the Habilitation Chair. | |
| JP2017137280A (ja) | 全身ｔテロメア１００％保持ゲノム創薬 | |
| 哈承旭 et al. | Effect of ammonium chloride on immunity related enzymes of “Huanghai No. 1” population of shrimp Fenneropenaeus chinensis | |
| CN302570663S (zh) | 电极 | |
| Moreno | Sustained ventricular fibrillation: case report | |
| Bauman et al. | Misophonia Physiological Response Scale (MPRS) |